| COVID-19 |
1 |
0.83 |
| Healthcare and Medical Technology |
0 |
0.76 |
| Electronic Health Record (EHR) |
0 |
0.68 |
| Translational Research |
0 |
0.45 |
| Health Administration |
0 |
0.42 |
| Genomic Medicine |
0 |
0.41 |
| Clinical Research |
0 |
0.34 |
| Data Collection |
0 |
0.34 |
| Electronic Medical Record |
0 |
0.34 |
| Epidemiology |
0 |
0.34 |
| Board Certification |
0 |
0.23 |
| Cancer |
0 |
0.23 |
| Clinical Guidelines |
0 |
0.23 |
| Diarrhea |
0 |
0.19 |
| Antimicrobial Resistance |
0 |
0.16 |
| Biomarker |
0 |
0.11 |
| Financing |
0 |
0.11 |
| Gastroenteritis |
0 |
0.11 |
| Health Care Services |
0 |
0.11 |
| Information Management |
0 |
0.11 |
| Microbicides |
0 |
0.11 |
| Ohio |
0 |
0.11 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.11 |